Have any thoughts about
Pcas SA?
Write Note

Wall Street
Price Targets

PCA Price Targets Summary
Pcas SA

There are no price targets for PCA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Pcas SA Competitors:
Price Targets
OABI
OmniAb Inc
178% Upside
CTKB
Cytek Biosciences Inc
31% Upside
HVO
hVIVO PLC
90% Upside
WAT
Waters Corp
4% Upside
FLB
Fluidigm Corp
56% Upside
SHC
Sotera Health Co
22% Upside
QGEN
Qiagen NV
15% Upside
LAB
Standard BioTools Inc
72% Upside

Revenue
Forecast

Revenue Estimate
Pcas SA

For the last 8 years the compound annual growth rate for Pcas SA's revenue is 4%. The projected CAGR for the next 4 years is -2%.

4%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Pcas SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Net Income
Forecast

Net Income Estimate
Pcas SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PCA's stock price target?
Not Available

PCA doesn't have any price targets made by Wall Street professionals.

What is Pcas SA's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Pcas SA's revenue is 4%. The projected CAGR for the next 4 years is -2%.

Back to Top